Glaxo SmithKline Pharmaceuticals Ltd
Requip Tablets 0.25mg
Requip Tablets 0.25mg
Product overview:
Product form: Tablets
Pack size: 21
Manufactured by: Glaxo SmithKline Pharmaceuticals Ltd
Prescription: Yes
Product Details
Requip Tablets 0.25mg contain ropinirole, a non-ergoline dopamine agonist that specifically targets the D2 and D3 dopamine receptor subtypes in the brain. By stimulating these receptors, Requip Tablets help alleviate symptoms associated with Parkinson’s disease. Ropinirole also has a moderate affinity for opioid receptors, contributing to its therapeutic effects in treating movement disorders.
Purposes
Requip Tablets 0.25mg are prescribed to reduce the symptoms of Parkinson’s disease, such as tremors, stiffness, and slowness of movement. By activating dopamine receptors in the brain, Requip Tablets can help improve motor function and enhance the quality of life for patients with Parkinson’s disease. This medication is also sometimes used to treat Restless Legs Syndrome (RLS).
Warnings
- Impulse Control Disorders: Requip Tablets 0.25mg may lead to unusual urges or behaviors, such as compulsive gambling, excessive eating, or increased sexual thoughts. Notify your doctor if you experience any of these symptoms.
- Pediatric Use: Requip Tablets are not recommended for individuals under 18 years of age.
- Withdrawal Symptoms: Stopping or reducing the dose of Requip Tablets may result in symptoms such as depression, anxiety, or lack of energy. If these issues persist, consult your doctor for dosage adjustments.
Adverse Effects
Common side effects of Requip Tablets 0.25mg include nausea, drowsiness, and dizziness. Some individuals may experience hallucinations, stomach pain, or swelling in the extremities. Uncommon side effects may include sudden sleep onset episodes, severe confusion, or paranoia.
Cautions
Before starting Requip Tablets 0.25mg, inform your doctor if you have a history of kidney or liver disease. This medication may exacerbate the dopaminergic side effects of L-dopa, potentially worsening preexisting dyskinesia in patients with Parkinson’s disease. Adjustments in L-dopa dosage may be necessary to mitigate these effects. Additionally, always consult your doctor before using Requip Tablets if you are pregnant or planning to become pregnant.
Store Requip Tablets 0.25mg at room temperature, away from direct light and heat, to maintain their effectiveness.